X-Energy Shares Hit Wall Street After IPO With Focus On Nuclear Potential
May 22, 2026

X-Energy Shares Hit Wall Street After IPO With Focus On Nuclear Potential

X-Energy shares held near $29 on Friday, about a month after its $23 Nasdaq IPO that raised $1.02 billion. The company will report first-quarter results June 4, its first as a public firm. Analysts have turned mostly positive, with price targets ranging from $28 to $57. The U.S. Nuclear Regulatory Commission cleared an environmental review for X-Energy’s Long Mott project in Texas this week.
Monarch Casino Shares Tick Higher With Holiday Looming, Legal Issue Still Present
May 22, 2026

Monarch Casino Shares Tick Higher With Holiday Looming, Legal Issue Still Present

Monarch Casino & Resort shares rose 0.6% to $116.91 Friday afternoon, as investors weighed record first-quarter results against a $78.5 million construction litigation liability. Net income jumped 38.9% to $27.6 million on revenue of $136.6 million. Monarch repurchased $17.6 million in shares and declared a 30-cent dividend. The move came ahead of the Memorial Day market closure.
VinFast Shares Drop as North Carolina Ups Ante
May 22, 2026

VinFast Shares Drop as North Carolina Ups Ante

VinFast shares fell Friday after North Carolina sued the company for allegedly breaching agreements on a stalled EV plant, seeking to recover about $80 million in state funds. The lawsuit followed VinFast’s announcement to sell its main Vietnamese manufacturing business and transfer $7 billion in debt. The company said it would review the suit and construction would begin soon. VinFast stock dropped despite broader Wall Street gains.

Larimar Shares Fall, FDA Submission Seen as Next Hurdle
May 22, 2026

Larimar Shares Fall, FDA Submission Seen as Next Hurdle

Larimar Therapeutics shares fell 3.36% to $3.45 Friday as investors awaited a planned June start to its rolling FDA application for nomlabofusp, a protein-replacement drug for Friedreich’s ataxia. The company ended March with $200.4 million in cash and projected funding into Q2 2027. Shareholders approved raising authorized common shares to 215 million. The FDA has approved only one other FA treatment to date.
Baker Hughes’ $13.6 Billion Chart Deal Gets EU Timing Shift—Why BKR Shares Moved
May 22, 2026

Baker Hughes’ $13.6 Billion Chart Deal Gets EU Timing Shift—Why BKR Shares Moved

Baker Hughes shares fell 0.59% to $65.41 in early New York trading Friday after EU regulators set a June 26 deadline for reviewing its $13.6 billion takeover of Chart Industries. The broader U.S. indexes were higher at the time. The European Commission could clear the deal or launch a deeper probe. Baker Hughes aims to expand in LNG and industrial technology with the acquisition.
Liberty Broadband Stock Jumps Before Long Weekend as Charter Deal Math Tightens
May 22, 2026

Liberty Broadband Stock Jumps Before Long Weekend as Charter Deal Math Tightens

Liberty Broadband Class A shares closed at $34.80 Thursday, up 3.14%, nearing the value implied by Charter Communications’ pending all-stock acquisition. The exchange ratio values each Liberty share at about $35.14 based on Charter’s $148.90 close. Trading is compressed before the Memorial Day holiday. Liberty’s stock is now mainly a play on Charter, which is also acquiring Cox Communications.

Larimar Shares Fall, FDA Submission Seen as Next Hurdle
May 22, 2026

Larimar Shares Fall, FDA Submission Seen as Next Hurdle

Larimar Therapeutics shares fell 3.36% to $3.45 Friday as investors awaited a planned June start to its rolling FDA application for nomlabofusp, a protein-replacement drug for Friedreich’s ataxia. The company ended March with $200.4 million in cash and projected funding into Q2 2027. Shareholders approved raising authorized common shares to 215 million. The FDA has approved only one other FA treatment to date.
Baker Hughes’ $13.6 Billion Chart Deal Gets EU Timing Shift—Why BKR Shares Moved
May 22, 2026

Baker Hughes’ $13.6 Billion Chart Deal Gets EU Timing Shift—Why BKR Shares Moved

Baker Hughes shares fell 0.59% to $65.41 in early New York trading Friday after EU regulators set a June 26 deadline for reviewing its $13.6 billion takeover of Chart Industries. The broader U.S. indexes were higher at the time. The European Commission could clear the deal or launch a deeper probe. Baker Hughes aims to expand in LNG and industrial technology with the acquisition.
Liberty Broadband Stock Jumps Before Long Weekend as Charter Deal Math Tightens
May 22, 2026

Liberty Broadband Stock Jumps Before Long Weekend as Charter Deal Math Tightens

Liberty Broadband Class A shares closed at $34.80 Thursday, up 3.14%, nearing the value implied by Charter Communications’ pending all-stock acquisition. The exchange ratio values each Liberty share at about $35.14 based on Charter’s $148.90 close. Trading is compressed before the Memorial Day holiday. Liberty’s stock is now mainly a play on Charter, which is also acquiring Cox Communications.
Kratos Shares Flat Around $55 as Cash Burn Looms Over Drone Defense Push
May 22, 2026

Kratos Shares Flat Around $55 as Cash Burn Looms Over Drone Defense Push

Kratos Defense & Security Solutions traded at $54.72 in premarket Friday after closing at $54.67 Thursday. The stock steadied near $55 as investors weighed strong defense growth against high spending and working-capital needs. U.S. equity markets will close Monday for Memorial Day. Kratos reported Q1 revenue up 22.6% to $371 million and raised its 2026 forecast.
Portillo’s Stock Near 52-Week Low as CFO Shake-Up Puts Turnaround Plan in Focus
May 22, 2026

Portillo’s Stock Near 52-Week Low as CFO Shake-Up Puts Turnaround Plan in Focus

Portillo’s shares traded at $4.10 premarket Friday, near a 52-week low, after the company named Pamela Smith interim CFO following Michelle Hook’s exit. The move comes weeks after Portillo’s reported a first-quarter net loss and flat same-restaurant sales. Analysts have lowered price targets and growth expectations as the chain slows expansion plans.
Veritone shares pop 16% as traders look at small AI firm with funding issues
May 21, 2026

Veritone shares pop 16% as traders look at small AI firm with funding issues

Veritone shares surged 16.3% to $2.28 on Thursday, with trading volume more than doubling from the previous day, despite no new company announcements. The move followed a recent earnings report showing first-quarter revenue down 9.8% to $20.3 million, but annual recurring revenue up 9.4% to $64.2 million. Market value reached about $212 million. The company reaffirmed its 2026 revenue forecast.

Latest

Microbot Medical Stock Faces a Holiday-Shortened Test After MBOT Slides on LIBERTY Doubts

Microbot Medical Stock Faces a Holiday-Shortened Test After MBOT Slides on LIBERTY Doubts

Microbot Medical shares fell 3.93% to $1.71 Friday, ending the week down 7.6%, despite the company reporting higher second-quarter revenue and more than doubling accounts for its LIBERTY robotic system. The stock dropped after White Diamond Research, holding a short position, questioned LIBERTY’s commercial prospects. Microbot scheduled an investor call to address the claims. U.S. markets will be closed Monday for Memorial Day.
Rambus Stock Rises Heading Into Memorial Day as AI Memory Stocks Wait for Next Move

Rambus Stock Rises Heading Into Memorial Day as AI Memory Stocks Wait for Next Move

May 23, 2026
Rambus Inc. shares jumped 12.5% to close at $142.98 Friday, outperforming the Nasdaq and PHLX semiconductor index ahead of the Memorial Day market closure. The stock rebounded midweek after early declines, gaining over 9% Wednesday and 6% Thursday. Rambus recently reported Q1 revenue of $180.2 million and raised its AI infrastructure profile with new PCIe 7.0 switch IP. A May 22 Form 144 filing signaled a planned insider share sale.
Beyond Meat Drops Below $1 Before Holiday Weekend

Beyond Meat Drops Below $1 Before Holiday Weekend

Beyond Meat shares closed Friday at $0.77, down 2.9%, falling below $1 ahead of the Memorial Day market closure. The stock lost 4.77% for the week, lagging the broader Nasdaq, and faces pressure to regain compliance with the exchange’s minimum bid rule. First-quarter revenue dropped 15.3% to $58.2 million, with a net loss of $28.5 million. Shareholders rejected executive pay in a recent advisory vote.
Korro Bio Stock Climbs Before Holiday; Bigger Test Still to Come

Korro Bio Stock Climbs Before Holiday; Bigger Test Still to Come

Korro Bio shares closed at $11.61 Friday, up 3.66% and about 14% above the May 15 close, before U.S. markets shut for Memorial Day. The company named KRRO-111 as its new AATD drug candidate after an earlier setback, reporting over 90% RNA editing in mouse models. Korro ended Q1 with $157.1 million in cash and a narrower net loss. H.C. Wainwright cut its price target to $15 from $20.
Bioceres Slips Before Holiday With Nasdaq Listing Deadline Ahead

Bioceres Slips Before Holiday With Nasdaq Listing Deadline Ahead

Bioceres Crop Solutions closed at $0.41 Friday, down 4.85%, as major U.S. indexes gained. The stock remains below Nasdaq’s $1 minimum bid price, with trading paused until Tuesday for Memorial Day. Bioceres reported a third-quarter net loss of $10 million and revenue down 23% to $39.4 million. The company is pursuing debt restructuring and a bond maturity extension in Argentina.
GH Research Stock Moves as Market Eyes Data in Holiday Week

GH Research Stock Moves as Market Eyes Data in Holiday Week

GH Research PLC shares closed at $22.12 Friday, up 1.6%, and traded higher after hours ahead of new depression-drug data presentations at a Miami conference next week. The company reported a Q1 net loss of $19 million and $267.3 million in cash at March 31, plus $111.2 million from an April stock offering. Wall Street analysts adjusted price targets citing share dilution.
CervoMed Stock Slides Into Long Weekend as CRVO’s Cash Clock Tests Phase 3 Hopes

CervoMed Stock Slides Into Long Weekend as CRVO’s Cash Clock Tests Phase 3 Hopes

CervoMed Inc. shares fell 11% this week, closing at $3.06 Friday after a first-quarter update highlighted funding needs for its planned Phase 3 dementia trial. The company reported $12.9 million in cash as of March 31, with a runway into September 2026. No grant revenue was recorded in Q1, and net loss widened to $8 million. Nasdaq is closed Monday for Memorial Day; trading resumes Tuesday.
Crown Crafts Stays Flat; $0.08 Dividend Keeps Eyes on June 11

Crown Crafts Stays Flat; $0.08 Dividend Keeps Eyes on June 11

Crown Crafts Inc. shares closed Friday at $2.75, flat for the week, with trading paused until Tuesday due to Memorial Day. The company’s $0.08 quarterly dividend, payable July 2, implies an 11.6% yield at current prices. Net sales fell to $20.7 million in the latest quarter, while net income rose to $1.5 million. China remains its main supplier, with tariffs and retail concentration flagged as risks.
Soleno Stock Delisted From Nasdaq After $2.9 Billion Neurocrine Deal

Soleno Stock Delisted From Nasdaq After $2.9 Billion Neurocrine Deal

Neurocrine Biosciences completed its $2.9 billion cash acquisition of Soleno Therapeutics, delisting Soleno from Nasdaq after a $53-per-share payout. The merger closed May 18, following a tender offer that secured 88.9% of Soleno shares. VYKAT XR, Soleno’s FDA-approved drug for Prader-Willi syndrome, generated $190 million in 2025 revenue. Nasdaq will next open after Memorial Day on Tuesday.
Wetour Robotics Stock Surges 91% Before Reverse Split, With AI Launch Next

Wetour Robotics Stock Surges 91% Before Reverse Split, With AI Launch Next

May 23, 2026
Wetour Robotics shares closed at $1.07 Friday, up 15.1% for the day and 91% from the prior week, with trading volume surging to 496,048 shares. The company will launch its Orchestra AI wearable in Austin on May 28 and enact a 1-for-10 reverse split on June 2. Nasdaq will be closed May 25 for Memorial Day. Wetour has an active at-the-market share sale program through Chaince Securities.